NEUROINTERVENTION IN SYSTEMIC ARTERIAL HYPERTENSION: THE ROLE OF RENAL SYMPATHETIC DENERVATION

Abstract

Systemic arterial hypertension (SAH) is a medically significant condition due to its implications for overall cardiovascular health. Despite the availability of effective pharmacological approaches, some patients continue to present with resistant hypertension, making blood pressure control challenging. In this context, neurointervention emerges as an innovative and promising strategy for treating SAH, with renal sympathetic denervation (RSD) standing out. The aim of this study is to provide a concise and informative overview of the current state of research in neurointervention, specifically focusing on renal sympathetic denervation (RSD) as a promising strategy for managing systemic arterial hypertension. The methodology involved a comprehensive and systematic search of the literature from three electronic databases (Medline, PubMed, and Scopus), with the selected articles synthesized to provide a comprehensive literature review. Based on the analysis of the literature, renal sympathetic denervation (RSD) emerges as an effective option for treating resistant hypertension, leading to significant improvements in blood pressure levels in patients undergoing the procedure. However, the study reveals that the treatment's effectiveness is not uniform across all patients with resistant hypertension, emphasizing the need for further research on renal sympathetic denervation and its long-term impact.